The Prevnar 20 approval comes a few weeks ahead of an FDA decision on Merck's V114, which was granted a priority review by the regulator in January for the prevention of IPD in adults.
Hosted on MSN2mon
Pfizer's enhanced pneumococcal vaccine arriving in Korea next year[PFIZER KOREA] Pfizer aims to release its latest pneumococcal vaccine, Prevnar 20, early next year in Korea. Prevnar, suitable for all individuals six weeks and older, offers protection against ...
Under the initiative, Buenos Aires-based Sinergium will produce Pfizer's Prevnar 20 in Argentina, with doses expected to be ready to roll out by 2026. In the meantime, countries across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback